A detailed history of Mather Group, Llc. transactions in Organon & Co. stock. As of the latest transaction made, Mather Group, Llc. holds 6,005 shares of OGN stock, worth $88,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,005
Previous 8,260 27.3%
Holding current value
$88,693
Previous $170,000 32.94%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$18.65 - $23.03 $42,055 - $51,932
-2,255 Reduced 27.3%
6,005 $114,000
Q2 2024

Jul 08, 2024

BUY
$17.45 - $21.96 $15,094 - $18,995
865 Added 11.7%
8,260 $170,000
Q1 2024

Apr 08, 2024

BUY
$13.78 - $18.8 $101,903 - $139,026
7,395 New
7,395 $139,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Mather Group, Llc. Portfolio

Follow Mather Group, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mather Group, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mather Group, Llc. with notifications on news.